Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Asian J Androl. 2007 Sep;9(5):690-6.

Protease activated receptor 2 and epidermal growth factor receptor are involved in the regulation of human sperm motility.

Author information

1
Department of Dermatology and Allergy, Technical University Munich, Biedersteiner Strasse 29, Munich, Germany. K.Zitta@gen.vetmed.uni-muenchen.de

Abstract

AIM:

To investigate mechanisms of tryptase-induced reduction of sperm motility and explore whether epidermal growth factor receptor (EGF-R) and protease activated receptor 2 (PAR-2)- associated pathways are involved.

METHODS:

Fresh semen was collected from healthy donors (n = 15). Semen parameters and quality were assessed in accordance with the World Health Organization (WHO) criteria. Swim-up sperm were fixed and subjected to immunocytochemistry and immunoelectronmicroscopy with specific antibodies directed against PAR-2 and EGF-R. Protein extractions from swim-up spermatozoa were analyzed by Western blotting with antibodies for both receptors. Motility of spermatozoa was evaluated by computer-assisted semen analysis.

RESULTS:

Immunocytochemistry found PAR-2 and EGF-R in approximately 30% of examined human ejaculated spermatozoa. Both receptors were localized in the plasma membrane. Like tryptase, the PAR-2 synthetic agonist SLIGKV reduced sperm motility, and this effect was inhibited by application of two specific EGF-R pathway blockers (AG1478 and PD168393).

CONCLUSION:

The observed reduction of sperm motility by tryptase through the PAR-2 receptor involves EGF-R pathways.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center